UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.334

Sortiert nach

Accuracy of random-forest-based imputation of missing data in the presence of non-normality, non-linearity, and interaction

BMC medical research methodology, 2020-07, Vol.20 (1), p.199-199, Article 199

2020

Volltextzugriff (PDF)

Cancer biomarkers

Molecular oncology, 2012-04, Vol.6 (2), p.140-146

2012

Volltextzugriff (PDF)

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-03, Vol.31 (7), p.961-965

2013

Volltextzugriff (PDF)

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Journal of clinical oncology, 2016-02, Vol.34 (6), p.611-635

2016

Volltextzugriff (PDF)

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

Journal of clinical oncology, 2012-03, Vol.30 (9), p.936-942

2012

Volltextzugriff (PDF)

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

CA: a cancer journal for clinicians, 2016-01, Vol.66 (1), p.43-73

2016

Volltextzugriff (PDF)

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

Molecular cell, 2012-08, Vol.47 (4), p.570-584

2012

Volltextzugriff (PDF)

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of clinical oncology, 2022-05, Vol.40 (13), p.1474-1486

2022

Volltextzugriff (PDF)

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4184-4193

2020

Volltextzugriff (PDF)

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes

Clinical biochemistry, 2016-12, Vol.49 (18), p.1354-1360

2016

Volltextzugriff (PDF)

Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.339-341

2019

Volltextzugriff (PDF)

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China

PloS one, 2019-11, Vol.14 (11), p.e0225361-e0225361

2019

Volltextzugriff (PDF)

Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children

Journal of allergy and clinical immunology, 2014-09, Vol.134 (3), p.593-601.e12

2014

Volltextzugriff (PDF)

Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Cancer, 2014-08, Vol.120 (16), p.2403-2411

2014

Volltextzugriff (PDF)

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Clinical cancer research, 2018-08, Vol.24 (15), p.3602-3610

2018

Volltextzugriff (PDF)

Breast cancer survivorship and sexual dysfunction: a population-based cohort study

Breast cancer research and treatment, 2023-07, Vol.200 (1), p.103-113

2023

Volltextzugriff (PDF)

Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms

JCO oncology practice, 2020-11, Vol.16 (11), p.733-739

2020

Volltextzugriff (PDF)

Serum Nutritional Biomarkers and All-Cause and Cause-Specific Mortality in U.S. Adults with Metabolic Syndrome: The Results from National Health and Nutrition Examination Survey 2001-2006

Nutrients, 2023-01, Vol.15 (3), p.553

2023

Volltextzugriff (PDF)

Patterns of human social contact and contact with animals in Shanghai, China

Scientific reports, 2019-10, Vol.9 (1), p.15141-11, Article 15141

2019

Volltextzugriff (PDF)

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

Clinical cancer research, 2015-06, Vol.21 (11), p.2487-2498

2015

Volltextzugriff (PDF)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol

Technology in cancer research & treatment, 2022, Vol.21, p.15330338221127169

2022

Volltextzugriff (PDF)

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Journal of clinical oncology, 2018-02, Vol.36 (4), p.326-332

2018

Volltextzugriff (PDF)

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations

Journal of clinical oncology, 2016-07, Vol.34 (19), p.2303-2311

2016

Volltextzugriff (PDF)

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study

Cancer epidemiology, biomarkers & prevention, 2023-10, Vol.32 (10), p.1302

2023

Volltextzugriff (PDF)

Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study

Supportive care in cancer, 2020-09, Vol.28 (9), p.4163-4172

2020

Volltextzugriff (PDF)

1 – 25 von 1.334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.147)
Mit Volltextzugriff
(1.144)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Accuracy of random-forest-based imputation of missing data in the presence of non-normality, non-linearity, and interaction

Cancer biomarkers

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes

Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?

Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China

Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children

Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Breast cancer survivorship and sexual dysfunction: a population-based cohort study

Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms

Serum Nutritional Biomarkers and All-Cause and Cause-Specific Mortality in U.S. Adults with Metabolic Syndrome: The Results from National Health and Nutrition Examination Survey 2001-2006

Patterns of human social contact and contact with animals in Shanghai, China

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study

Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study

Suchergebnisse filtern